Vertex Pharmaceuticals (VRTX)
$464.6 0%
to add to portfolio
AI Score
-
Alternative
8 -
Fundamental
8 -
Technical
5
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Vertex Pharmaceuticals, AI stock picks, stock alerts and much more.
VRTX AI Stock Analysis
AI stock analysis for VRTX is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Vertex Pharmaceuticals (VRTX) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
VRTX Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Vertex Pharmaceuticals (VRTX), currently trading at $464.6, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About VRTX
-
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis.
-
Symbol
VRTX
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
119.6B
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$22.34 1.9% |
6 |
 |
Inovio Pharmaceuticals INO |
$4.19 4.5% |
2 |
 |
Moderna MRNA |
$43.39 3.2% |
4 |
 |
Anavex Life Sciences AVXL |
$9.03 0.1% |
4 |
 |
BridgeBio Pharma BBIO |
$27.49 4% |
5 |
News
VRTX Alternative Data
News Mentions
Sign up to access
Twitter Followers
Sign up to access
Instagram Followers
Sign up to access
Youtube Subscribers
Sign up to access
LinkedIn Followers
Sign up to access
LinkedIn Employees
Sign up to access
Job Postings
Sign up to access
Web Traffic
Sign up to access
Business Outlook
Sign up to access
VRTX Financials
VRTX Key Metrics
-
Total Revenue
$2.8B
-
Net Income
$1B
-
Earnings per Share
$4.05
-
Free cash flow
$1.5B
-
EBITDA
$1.1B
-
EBITDA Ratio
0.40272
-
Total Assets
$22.2B
VRTX 2-year Revenue & Income
VRTX 2-year Free Cash Flow
VRTX Technicals
VRTX SMA
VRTX RSI
FAQ
What's the current price of Vertex Pharmaceuticals (VRTX) Stock?
The price of an Vertex Pharmaceuticals (VRTX) share is $464.6.
What's the market cap of Vertex Pharmaceuticals?
The current market cap of Vertex Pharmaceuticals is 119.6B.
Should I buy or sell VRTX?
Multiple alternative data signals suggest that Vertex Pharmaceuticals stock could offer a buying opportunity at its current level, with a reasonable expectation for positive performance in the mid term.
Is Vertex Pharmaceuticals a good investment?
Based on an in-depth analysis that encompasses fundamentals, technical analysis, and alternative data insights, it appears to be a favorable time to consider investing in Vertex Pharmaceuticals stock. The bullish indicators suggest that Vertex Pharmaceuticals' growth prospects and market position may lead to a positive performance in the foreseeable future.
Is now a good time to buy Vertex Pharmaceuticals (VRTX) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it could be a favorable time to consider buying Vertex Pharmaceuticals stock, given the bullish outlook.
What are some stocks similar to Vertex Pharmaceuticals (VRTX) that investors often compare it to?
Vertex Pharmaceuticals (VRTX) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Vertex Pharmaceuticals' stock price in 2025?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Vertex Pharmaceuticals' stock price to be around $516.6 in 2025. Starting from the current price of $464.6, this represents a 11.2% change in price, indicating a bullish outlook for the stock.
How to buy Vertex Pharmaceuticals (VRTX) Stock?
Vertex Pharmaceuticals stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Vertex Pharmaceuticals shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.